
23andMe Collapses: DNA Testing Giant Files for Bankruptcy, CEO Resigns
Genetic testing company 23andMe (NASDAQ:ME) has filed for Chapter 11 bankruptcy protection in a Missouri federal court, marking a dramatic fall for a company once valued at nearly US$6 billion. Alongside the bankruptcy, the Associated Press reported that co-founder Anne Wojcicki has stepped down as chief executive, effective immediately, though she will remain on the…